CRISPR

Solugen, a startup that has set itself up with no less lofty a goal than the decarbonization of a massive chunk of the petrochemical industry, may be the first legitimate multi-million-dollar company

Yesterday, the World Health Organization wrapped up its first meeting of a new advisory committee set up to create global governance and oversight standards for human gene editing. The committee was h

With the announcement today that Mammoth Biosciences has received the exclusive license from the University of California, Berkeley to the new CRISPR protein Cas14, the company now has the last piece

Chinese authorities have declared the work of He Jiankui, who shocked the scientific community by claiming he successfully created the world’s first gene-edited babies, an illegal decision in p

The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was announced yesterday points toward a new path for CRISPR gene editing te

Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can creat

Update: The story is getting even more convoluted. When contacted by TechCrunch’s Rita Liao, a representative at the hospital that supposedly approved Jiankui He’s study stated “what

Paul Dabrowski, the chief executive officer of Synthego, which provides genetically engineered cells to scientists and researchers, worries about a future where access to the genetic technologies that

At least 2 million people in the U.S. become infected with so-called “super bugs” and at least 23,000 people die as a direct result of these infections each year, according to the Centers

Mammoth Biosciences, the biotech company that grew out of a close relationship with CRISPR legend Jennifer Doudna, has raised $23 million in a sturdy Series A. Mammoth previously raised $120,000 from

CRISPR-Cas9, the gene editing tool that is currently the darling of biotech and many other fields, may not be quite as miraculous as early tests suggested. A new study finds that what scientists thoug

Most people tend to think of CRISPR as a groundbreaking gene-editing technology that can hunt down and snip away bits of DNA, like the cut and paste function on a keyboard. While many research project

A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a

The CRISPR-Cas9 gene-editing technique is an important concept to know about in these days of biotech advances, but it can be pretty difficult to visualize properly. Is it really like molecular scisso

While the U.S. is just gearing up to the idea of CRISPRing its first humans, China seems to be benefiting from the “move fast and break things” — or cut them with the CRISPR scissors

As the New Year dawns, new opportunities are emerging for savvy venture capitalists in a number of different fields. From new companies building businesses based on the genome, to businesses built on

It is incumbent for us, the technology community, to reach out to the regulators and legislators to help them better understand the wider impact of the things we’re working on. And it’s our respon

We truly live in amazing times. Chinese scientists just made skinnier pigs using CRISPR-Cas9 technology. Do you know what this means? Low-fat bacon! I know, I know, for some, bacon without the fat doe

Gene-editing technology CRISPR has revealed a clue in how human embryos begin to develop, possibly reducing the risk of miscarriage in those crucial first few weeks of pregnancy. CRISPR Cas9 can modif

Pig organs are the same size as human organs and function pretty much the same way, but pig to human transplantation has long been an elusive goal for researchers due to fear of activating dormant vir